Treatment-related side effects and quality of life in cancer patients

Supportive Care in Cancer

Volumn 20, Issue 10, 2012, Pages 2553-2557

  Mazzotti, Eva ^a   Antonini Cappellini, Gian Carlo ^a   Buconovo, Stefania ^a   Morese, Roberto ^a   Scoppola, Alessandro ^a   Sebastiani, Claudia ^a   Marchetti, Paolo ^a,b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cancer patients; Quality of life; Treatment related; Well being

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; COLON CANCER; DEMOGRAPHY; DRUG FEVER; DRUG INDUCED DISEASE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GENERAL HEALTH QUESTIONNAIRE; HEALTH STATUS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MENTAL DISEASE; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT MONITORING; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; SHORT FORM 36; STOMATITIS; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 84868384680     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1354-y     Document Type: Article

References (31)

1. Aktas A, Walsh D, Rybicki L (2010) Symptom clusters: myth or reality? Palliat Med 24(4):373-385
2. Bleiker EMA, Pouwer F, van der Ploeg HM, Leer J-WH, Ader HJ (2000) Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient Education and Counseling 40:209-217 (Pubitemid 30317327)
3. Butcher L (2008) Shared decision-making aids improving, winning support among both patients and physicians for treatment choices. Oncology Times 30(10):23-26. doi:10.1097/01. COT.0000320575.58527.86
4. Cella D (2009) Quality of life in patients with metastatic renal cell carcinoma: the importance of patient-reported outcomes. Cancer Treatment Reviews 35:733-737
5. Collins ED, Moore CP, Clay KF et al (2009) Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol 27(4):519-525
6. Fallowfield L, Ratcliffe D, Jenkins V, Saul J (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011-1015 (Pubitemid 32448494)
7. Goldberg DP (1972) The detection of psychiatric illness by questionnaire. Oxford University Press, London
8. Holland JC, Alici Y (2010) Management of distress in cancer patients. J Supp Oncology 8(1):4-12
9. Keller M, Sommerfeldt S, Fischer C, Knight L, Riesbeck M, Lowe B et al (2004) Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Annals of Oncology 15:1243-1249 (Pubitemid 39199312)
10. Kim HJ, Barsevick AM, Tulman L, McDermott PA (2008) Treatment-related symptom clusters in breast-cancer: a secondary analysis. Journal of Pain and Symptom Management 36(5):468-479
11. Kirkova J, Davis MP, Walsh D, Tiernan E, O'Leary N, LeGrand SB et al (2006) Cancer symptom assessment instruments: a systematic review. J Clin Oncol 24(9):1459-1473 (Pubitemid 46622014)
12. Kirkova J, Rybicki L, Walsh D, Aktas A, Davis MP, Karafa MT (2010) The relationship between symptom prevalence and severity and cancer primary site in 796 patients with advanced cancer. Am J Hosp Palliat Care 28(50):350-355
13. Kirkova J, Walsh D, Rybicki L, Davis MP, Aktas A, Tao J et al (2010) Symptom severity and distress in advanced cancer. Palliat Med 24(3):330-339
14. Krespi Boothby MR, Hill J, Holcombe C, Clark L et al (2010) The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients. Turk Psikiyatri Dergisi 21(1):49-59
15. Mehnert A, Koch U (2008) Psychological comorbidity and healthrelated quality of life and its association with awareness, utilization, and need for psychosocial support in cancer register-based sample of long-term breast cancer survivors. J Psychosomatic Research 64(4):383-391 (Pubitemid 351417917)
16. National Comprehensive Cancer Network (2009) Distress management clinical practice guidelines in oncology, version 1 (www. nccn.org/professionals/ physician-gls/f-guidelines.asp#supportive)
17. Piccinelli M, Bisoffi G, Bon MG et al (1993) Validity and test- retest reliability of the Italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods. Compr Psychiatry 34:198-205 (Pubitemid 23170659)
18. Porzio G, Valenti M, Aielli F, Verna L, Ricevuto E, Rispoli AI et al (2005) Assessment and treatment of symptoms among Italian medical oncologists. Supportive Care Cancer 13:865-869 (Pubitemid 41502245)
19. Prouse J (2010) The impact of methods of information on chemotherapy-related side effects. Clin J Oncol Nurs 14(2):206-211
20. Raphael J, Hester J, Ahmedzai S et al (2010) Cancer pain, part 2. Physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 11(6):872-896
21. Richardson LC, Wang W, Hartzema AG, Wagner S (2007) The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Breast J 13(6):581-587 (Pubitemid 350045708)
22. Rose MS, Koshman ML, Spreng S, Sheldon R (1999) Statistical issues encountered in the comparison of health-related quality of life in diseased patients to published general population norms: problems and solutions. J Clin Epidemiol 52:405-412 (Pubitemid 29305345)
23. Schofield P, Jefford M, Carey M, Thomson K, EvansM, Baravelli C et al (2008) Preparing patients for threatening medical treatments: effects of a chemotherapy educational DVD on anxiety, unmet needs, and self-efficacy. Support Care Cancer 16:37-45 (Pubitemid 350243758)
24. Sioka C, Kyritsis AP (2009) Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 63(5):761-767
25. So WKW, Marsh G, Ling WM, Leung FY, Lo JCK, Yeung M et al (2009) The symptom cluster of fatigue, pain, anxiety and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncology Nursing Forum 36(4):E205-E214
26. Spichiger E,Muller-Frohlich C, Denhaerynch K, Stoll H, Hantikainen V, Dodd M (2011) Symptom prevalence and changes of symptoms over ten days in hospitalized patients with advanced cancer: a descriptive study. Europ J Oncol Nursing 15(2):95-102
27. Streiner DL (2002) Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry 47:262-266 (Pubitemid 34614684)
28. Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34(1):94-104 (Pubitemid 46970881)
29. Ware JE, Kosinski M (2001) SF-36 physical and mental health summary scales: a manual for users of version I. (2nd ed.). Quality Metric Incorporated, Lincoln
30. Yamagishi A, Morita T, Miyashita M, Kimura F (2009) Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy. J Pain Symptom Manage 37(5):823-830
31. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho-Oncology 10(1):19-28 (Pubitemid 32106774)